Navigation Links
RainDance Technologies to Dedicate New Headquarters, Manufacturing Facility in Lexington
Date:9/17/2008

- Biomedical technology innovator relocates to Mass. based upon Gov. Deval

Patrick's Life Sciences Initiative -
LEXINGTON, Mass., Sept. 17 /PRNewswire/ --

-- WHO: RainDance Technologies

-- WHAT: Dedication of its new HQ/manufacturing facility

-- WHEN: Friday, Sept. 26, 2008, 3:00 p.m. to 5:00 p.m. EDT

-- WHERE: 44 Hartwell Avenue, Lexington, Mass.

RainDance Technologies, Inc., a provider of innovative droplet-based microfluidic solutions for human health and disease research, will dedicate its new headquarters and commercial and manufacturing operations on Friday, Sept. 26th in Lexington, Mass. at 3:00 p.m.

RainDance's 28,000-square-foot building in Lexington will more than double its former space in Guilford, Conn. RainDance plans to increase its workforce by some 50 percent -- adding new biologists and chemists, mechanical engineers and technicians, software programmers, customer service representatives, and administrative support -- and will employ nearly 100 within the year.

Company officials made the decision to relocate to Massachusetts based on Governor Deval Patrick's Life Sciences Initiative.

RainDance will also announce a collaboration with a major pharmaceutical company to develop a new droplet-based methodology for the drug discovery process.

Agenda:

-- Remarks:

-- Sir Richard Roberts, Nobel Laureate, Physiology/ Medicine, 1993,

RainDance Technologies Scientific Advisory Board

-- Daniel O'Connell, Massachusetts Housing and Economic Development

Secretary

-- Christopher McNary, RainDance Technologies President and Chief

Executive Officer

-- A tour of our new facilities and reception will follow.

RainDance's new RainStorm(TM) droplet-based microfluidic technology has broad use in the prediction and prevention of human disease. The simplicity, speed, and capabilities of the technology will enable researchers to design experiments in ways previously unaffordable or unimaginable. RainStorm technology will find numerous uses in biomedical applications, including genomics research, gene expression analysis, compound screening, and biomarker detection.

RainDance was founded by scientists from Harvard University, the Medical Research Centre in Cambridge, England, and the ESPCI in Paris, and the company's scientific advisers include three Nobel Prize winners plus a pioneer in protein engineering who has been knighted for services to molecular biology.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Steven Becker https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78145


'/>"/>
SOURCE RainDance Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. RainDance and Scripps to Collaborate on Targeted Sequencing for Wellderly Study
2. RainDance Technologies Appoints Olex Vice President, System Development
3. RainDance Appoints Kelly Chief Operating Officer
4. RainDance Announces Company Relocation and Manufacturing Startup
5. RainDance Appoints Becker Chief Commercial Officer
6. RainDance Technologies Appoints McNary President and CEO
7. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
8. Tethys Bioscience Announces Acquisition of Lipomics Technologies
9. Althea Technologies Secures $12 M Credit Line to Continue Facility Growth and Expansion
10. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
11. Neptune Technologies decided not to re-price options
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... 1, 2016 asking the Federal Drug Administration (FDA) to consider OA as a ... OARSI is concerned about the growing population of OA patients, many of whom ...
(Date:12/6/2016)... ... December 06, 2016 , ... Clinical ... it has acquired the assets of Theorem Clinical Research - Clinical Supplies ... clinical trial drug packaging, labeling, storage, reconciliation, and distribution for pharmaceutical trials ...
(Date:12/6/2016)... 6, 2016  SRI International has been awarded ... the National Institutes of Health,s National Institute of ... AIDS (NIAID-DAIDS) to support the manufacturing and characterization ... agents. Under the seven-year contract, SRI will provide ... for candidate HIV-prevention products that emerge from investigator-initiated ...
(Date:12/5/2016)... Axovant Sciences Ltd. (NYSE: AXON ... treatment of dementia, today announced that data on the ... disease will be presented at the 2016 Clinical Trials ... 2016 in San Diego . Intepirdine ... and complex measures of activities of daily living (ADLs) ...
Breaking Biology Technology:
(Date:11/22/2016)... 22, 2016 According to the new market research ... Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and ... the market is expected to grow from USD 10.74 Billion in 2015 ... between 2016 and 2022. Continue Reading ... ...
(Date:11/21/2016)... 2016   Neurotechnology , a provider of ... announced that the MegaMatcher On Card fingerprint matching ... the NIST Minutiae Interoperability Exchange (MINEX) III ... steps of the evaluation protocol. ... of fingerprint templates used to establish compliance of ...
(Date:11/17/2016)... -- Global Market Watch: Primarily supported by ownership ... and Academics) market is to witness a value of US$37.1 ... highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen ... period 2014-2020. North America is not ... Europe at 9.56% respectively. Report Focus: ...
Breaking Biology News(10 mins):